Those on certain prescribed medications, such as the long-term use of antacids and metformin, may be at risk of lower levels of B12 and should seek advice from their GP
The most common side effects of Mounjaro include nausea, vomiting, diarrhoea, and constipation
FDA determined on December 19, 2024 that the tirzepatide injection shortage was resolved, and on February 21, 2025 that the semaglutide injection shortage was resolved
Understanding this will lay the groundwork for exploring its potential benefits beyond diabetes and weight loss
doi: 10.3389/fpsyt.2026.1893173 Received 28 May 2026 Revised 16 June 2026 Accepted 16 June 2026 Published 24 July 2026 Volume 17 - 2026 Edited by Matej Stuhec, University of Maribor, Slovenia Reviewed by Borjanka Batinic, University of Belgrade, Serbia Miodrag Janic, University Medical Centre Ljubljana, Slovenia Updates Copyright 2026 Alanazi and Alanazi